Avalon-GSK Partnership to Welcome 2 More Cos. to the World

I have the hazy outlines of a scoop for you, my dear readers:

Two more companies have been born out of Avalon Ventures’ unconventional, $495 million alliance with British pharma giant GlaxoSmithKline PLC, according to Douglas Downs, a managing partner and chief financial officer at Avalon Ventures...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

• 52 weekly issues
• Subscriber-only digital content every business day, plus full access to SDBJ.com archives
• Book of Lists — the most comprehensive business resource in San Diego
• San Diego 500 — influential business leaders you need to know

Yours for only $129

First name:

Last name:

Email:

Address:

Zip:

CC Number:

Cvv:

Exp Month:

Exp Year: